Meditoxin 100 iu Botox Made In Korea. The meditox bottle looks empty, white powder is present in such small quantities that you can barely see it, it is a feature of this product, so don't buy this product if you think it is not good.
Fast shipping worldwide with DHL, EMS, Etc.
Buy Meditoxin online 100iu (Botulinux A toxin) 100 units
Meditoxin is a type A botulinum toxin (100 units) produced by Medy-Tox Inc. in Korea since 2006. Clostridium botulinum had been studied by Korean scientists in the 1980s, they then founded a biotechnology company called "Medy-Tox. Inc. After many experiments on the biological, biochemical, immunological and toxicity aspects, botulinum toxin type A became a biopharmaceutical product.
In 2004 Meditoxin® was licensed to famous pharmaceutical companies such as Ranbaxy who introduced Meditoxin to the South American market while the partner Q-MED has been involved in marketing in Europe and Japan since 2007. All this makes it clear how reliable the Meditoxin brand is. . MEDITOXIN offers first-class botulinum toxins A with a good quality-price ratio when compared to Botox from Allergan, USA.
Duration of effects:
The effect of Botox meditoxin treatment lasts for 4-6 months. Treatment should be repeated after 6-9 months to maintain results. Repeating treatments with botulinum has no harmful effects.
Generally the botulinum toxin if administered in the correct way does not cause damage, obviously it has contraindications like all the other brands of botox.
The use of the botulinum for unapproved indications leads to greater risks such as weakness of the facial muscles or fall of the lip.
Treatment with the Korean Botox Meditoxin lasts about 20 minutes, is non-invasive and allows you to rejuvenate your face. Botulinum Meditoxin creates significant changes with small injections and has very high satisfaction rates.
Indications and use
Botox Meditoxin is useful in the following cases:
- Benign essential blepharospasm in adults over 18 years of age
- Foot deformities due to spasticity in pediatric patients with cerebral palsy over 2 years of age
- Improvement of moderate to severe globallary wrinkles of the eyebrow (wave muscle)
- Muscle spasticity of the upper limb following a stroke in adults over 20 years of age.